Replies to post #87858 on Biotech Values

[genisi]

Pfizer/Athersys - Big pharmaceutical companies and Stem-Cell Therapy

Novo Nordisk is working with Cellartis on stem-cell treatments for diabetes. Johnson & Johnson has invested in Novocell and Tengion, another regenerative medicine company. GlaxoSmithKline is providing $25 million to Harvard’s stem-cell institute. And Novartis and Roche have invested in Cellerix, a Spanish stem-cell company.

The writer neglected to mention the fact that Teva has a large stake in Gamida Cell's StemEx product, currently in phase II/III for treatment of hem-cancer.